5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The accuracy of reverse genetics systems for SARS‐CoV‐2: Circular polymerase extension reaction versus bacterial artificial chromosome

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Reverse genetics systems to rescue viruses from modified DNA are useful tools to investigate the molecular mechanisms of viruses. The COVID‐19 pandemic prompted the development of several reverse genetics systems for SARS‐CoV‐2. The circular polymerase extension reaction (CPER) method enables the rapid generation of recombinant SARS‐CoV‐2; however, such PCR‐based approaches could introduce unwanted mutations due to PCR errors.

          Methods

          To compare the accuracy of CPER and a classic reverse genetics method using bacterial artificial chromosome (BAC), SARS‐CoV‐2 Wuhan/Hu‐1/2019 was generated five times using BAC and five times using CPER. These 10 independent virus stocks were then deep sequencing, and the number of substitutions for which the frequency was greater than 10% was counted.

          Results

          No nucleotide substitutions with a frequency of greater than 10% were observed in all five independent virus stocks generated by the BAC method. In contrast, three to five unwanted nucleotide substitutions with a frequency of more than 10% were detected in four of the five virus stocks generated by the CPER. Furthermore, four substitutions with frequencies greater than 20% were generated in three virus stocks by using the CPER.

          Conclusions

          We found that the accuracy of the CPER method is lower than that of the BAC method. Our findings suggest care should be used when employing the CPER method.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

          Summary The mode of acquisition and causes for the variable clinical spectrum of COVID-19 remain unknown. We utilized a reverse genetics system to generate a GFP reporter virus to explore SARS-CoV-2 pathogenesis and a luciferase reporter virus to demonstrate sera collected from SARS and COVID-19 patients exhibited limited cross-CoV neutralization. High-sensitivity RNA in situ mapping revealed the highest ACE2 expression in the nose with decreasing expression throughout the lower respiratory tract, paralleled by a striking gradient of SARS-CoV-2 infection in proximal (high) vs distal (low) pulmonary epithelial cultures. COVID-19 autopsied lung studies identified focal disease and, congruent with culture data, SARS-CoV-2-infected ciliated and type 2 pneumocyte cells in airway and alveolar regions, respectively. These findings highlight the nasal susceptibility to SARS-CoV-2 with likely subsequent aspiration-mediated virus seeding to the lung in SARS-CoV-2 pathogenesis. These reagents provide a foundation for investigations into virus-host interactions in protective immunity, host susceptibility, and virus pathogenesis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

            A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused a large respiratory outbreak in Wuhan, China in December 2019, is currently spreading across many countries globally. Here, we show that a TMPRSS2-expressing VeroE6 cell line is highly susceptible to SARS-CoV-2 infection, making it useful for isolating and propagating SARS-CoV-2. Our results reveal that, in common with SARS- and Middle East respiratory syndrome-CoV, SARS-CoV-2 infection is enhanced by TMPRSS2.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

              During the current coronavirus disease 2019 (COVID-19) pandemic, a variety of mutations have accumulated in the viral genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, at the time of writing, four variants of concern are considered to be potentially hazardous to human society 1 . The recently emerged B.1.617.2/Delta variant of concern is closely associated with the COVID-19 surge that occurred in India in the spring of 2021 (ref. 2 ). However, the virological properties of B.1.617.2/Delta remain unclear. Here we show that the B.1.617.2/Delta variant is highly fusogenic and notably more pathogenic than prototypic SARS-CoV-2 in infected hamsters. The P681R mutation in the spike protein, which is highly conserved in this lineage, facilitates cleavage of the spike protein and enhances viral fusogenicity. Moreover, we demonstrate that the P681R-bearing virus exhibits higher pathogenicity compared with its parental virus. Our data suggest that the P681R mutation is a hallmark of the virological phenotype of the B.1.617.2/Delta variant and is associated with enhanced pathogenicity. The P681R mutation in the spike protein renders the Delta variant more pathogenic than prototypic SARS-CoV-2 in infected hamsters, and facilitates spike protein cleavage and enhances viral fusogenicity.
                Bookmark

                Author and article information

                Contributors
                yoshihiro.kawaoka@wisc.edu
                Journal
                Influenza Other Respir Viruses
                Influenza Other Respir Viruses
                10.1111/(ISSN)1750-2659
                IRV
                Influenza and Other Respiratory Viruses
                John Wiley and Sons Inc. (Hoboken )
                1750-2640
                1750-2659
                17 March 2023
                March 2023
                : 17
                : 3 ( doiID: 10.1111/irv.v17.3 )
                : e13109
                Affiliations
                [ 1 ] Division of Virology, Institute of Medical Science University of Tokyo Tokyo Japan
                [ 2 ] The Research Center for Global Viral Diseases National Center for Global Health and Medicine Research Institute Tokyo Japan
                [ 3 ] International Research Center for Infectious Diseases, Institute of Medical Science University of Tokyo Tokyo Japan
                [ 4 ] Department of Pathobiological Sciences, School of Veterinary Medicine University of Wisconsin‐Madison Madison Wisconsin USA
                Author notes
                [*] [* ] Correspondence

                Yoshihiro Kawaoka, Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

                Email: yoshihiro.kawaoka@ 123456wisc.edu

                Author information
                https://orcid.org/0000-0002-7489-7303
                https://orcid.org/0000-0001-7768-5157
                Article
                IRV13109
                10.1111/irv.13109
                10020915
                36935846
                dc810682-9c9b-440c-9ce0-5d2f5171ba00
                © 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 01 February 2023
                : 06 December 2022
                : 02 February 2023
                Page count
                Figures: 0, Tables: 2, Pages: 4, Words: 2260
                Funding
                Funded by: Center for Research on Influenza Pathogenesis
                Award ID: HHSN272201400008C
                Funded by: National Institute of Allergy and Infectious Diseases , doi 10.13039/100000060;
                Award ID: 75N93021C00014
                Funded by: Japan Agency for Medical Research and Development , doi 10.13039/100009619;
                Award ID: JP21nf0101632
                Award ID: JP223fa627001
                Award ID: JP22wm0125002
                Categories
                Short Communication
                Short Communications
                Custom metadata
                2.0
                March 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.6 mode:remove_FC converted:17.03.2023

                Infectious disease & Microbiology
                bac,cper,reverse genetics,sars‐cov‐2
                Infectious disease & Microbiology
                bac, cper, reverse genetics, sars‐cov‐2

                Comments

                Comment on this article